Comparing Solifenacin vs Urispas
Solifenacin | Urispas (flavoxate) |
|
---|
Solifenacin | Urispas (flavoxate) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Overactive Bladder, Urinary Incontinence, Urinary Frequency, Neurogenic Bladder, Neurogenic Detrusor Overactivity. Solifenacin may also be used for purposes not listed in this medication guide. View more |
Prescription only
Prescribed for Urinary Frequency, Dysuria, Urinary Incontinence. Urispas may also be used for purposes not listed in this medication guide. |
Related suggestions Urinary Frequency
Urinary Incontinence
Popular comparisons
|
|||||||
More about Solifenacin | More about Urispas (flavoxate) | ||||||||
Ratings & Reviews | |||||||||
Solifenacin has an average rating of 5.6 out of 10 from a total of 213 ratings on Drugs.com. 39% of reviewers reported a positive effect, while 35% reported a negative effect. |
Urispas has an average rating of 7.7 out of 10 from a total of 3 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 33% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Solifenacin side effects |
View all Urispas side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
Lower cost generic |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all Solifenacin prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | |||||||||
|
N/A |
||||||||
Brand Names | |||||||||
VESIcare, VESIcare LS |
N/A |
||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
68 hours |
N/A |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 497 drugs are known to interact with Solifenacin:
|
A total of 330 drugs are known to interact with Urispas:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
November 19, 2004 |
January 15, 1970 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
VESIcare
Vesicare is used to treat symptoms of overactive bladder such as incontinence and frequent ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Myrbetriq
Myrbetriq (mirabegron) is used to treat overactive bladder with symptoms of frequent or urgent ...
Gemtesa
Gemtesa (vibegron) is used to treat overactive bladder symptoms (OAB) in adults or men taking ...
Estrace
Estrace (estradiol) is used to treat symptoms of menopause such as hot flashes and vaginal dryness ...
Trospium
Trospium is used for interstitial cystitis, overactive bladder, urinary frequency, urinary incontinence
Tolterodine
Tolterodine is used for overactive bladder, urinary frequency, urinary incontinence
Mirabegron
Mirabegron is used for neurogenic detrusor overactivity, overactive bladder, urinary frequency ...
Oxybutynin
Oxybutynin is used to treat symptoms of overactive bladder such as incontinence. Learn about side ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.